Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis

By Baumgarten Miriam   Polanski Lukasz   Campbell Bruce   Raine-Fenning Nick  

Human Fertility, Vol. 16, Iss. 3, 2013-09 ,pp. : 168-174

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite

Cabergoline as treatment of ovarian hyperstimulation syndrome: a review

By Kalampokas Theodoros   Creatsas George   Kalampokas Emmanouil  

Gynecological Endocrinology, Vol. 29, Iss. 2, 2013-02 ,pp. : 98-100

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment

By Egbase P.E.  

Human Reproduction, Vol. 15, Iss. 10, 2000-10 ,pp. : 2082-2086

Oxford University Press

Access to resources Recommend Favorite

Comparison of bevacizumab and cabergoline in the treatment of ovarian hyperstimulation syndrome in a rat model

By Engin-Ustun Yaprak   Yılmaz Saynur   Timur Hakan   Ustun Yusuf   Moraloglu Ozlem   Deveer Ruya   Yılmaz Nafiye  

Gynecological Endocrinology, Vol. 29, Iss. 9, 2013-09 ,pp. : 851-854

Informa Healthcare

Access to resources Recommend Favorite